(August 6, 2020 / Israel Hayom) Israeli Defense Minister Benny Gantz said on Thursday that the Jewish state will soon begin human trials on a potential COVID-19 vaccine.
Gantz, who visited the Israel Institute for Biological Research earlier in the day to monitor the early stages of the vaccine’s development, said a group of Israelis will start getting shots after the High Holidays in September.
The institute, which is run under the auspices of the Defense Ministry, has recently said it has had promising results in lab testing for a potential vaccine. Some of those findings were shown to Gantz on Thursday.
According to Israel Hayom, the vaccine’s production line will be in Israel, but the antibody production, which is less sophisticated, will be carried out abroad due to high costs.
“Just like the Israel Defense Forces has special units that go behind enemy lines to clear the way forward, you are Israel’s special forces when it comes to vaccines,” Gantz told the institute’s staff.
The first phase of the human clinical trial will look to evaluate its safety.
The second phase, which may get a green light even as the first phase is being carried out, will determine its effectiveness on a small sample, with the final stage involving widespread injections on a large group of people, while observing a control group, to determine its overall impact in fending off the disease among the population.
This article first appeared in Israel Hayom.
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.